Dr Reddy’s posts lower-than-expected Q1 results; stock tanks 8% - Details investors should know
The pharmaceutical major Dr Reddy’s Laboratories on Tuesday reported a 1 per cent decline in the consolidated net profit to Rs 571 crore in the first quarter of the financial year 2021-2022. The company had posted Rs 579 crore in the same period a year ago (Q1FY21).
Dr Reddy's shares declined almost 8 per cent to Rs 4982 per share, a day’s low level: PTI